4//SEC Filing
Gullans Steven R. Ph.D. 4
Accession 0001596771-18-000009
CIK 0001638287other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:06 PM ET
Size
5.4 KB
Accession
0001596771-18-000009
Insider Transaction Report
Form 4
Gullans Steven R. Ph.D.
Director
Transactions
- Award
Employee Stock Option (right to buy)
2018-01-29+60,000→ 60,000 totalExercise: $10.44Exp: 2028-01-28→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option vests in 12 equal consecutive monthly installments on the last day of each month, commencing on the grant date, subject to acceleration upon the appointment of a permanent President and Chief Executive Officer.
Documents
Issuer
Gemphire Therapeutics Inc.
CIK 0001638287
Entity typeother
Related Parties
1- filerCIK 0001571997
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:06 PM ET
- Size
- 5.4 KB